Skip to search formSkip to main contentSkip to account menu

Refractory Adult Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia that occurs in adulthood and does not respond to treatment.
National Institutes of Health

Related topics

Related topics

13 relations
Atypical lymphocyteBone MarrowHematopoietic and Lymphoid CellHematopoietic and Lymphoid Tissue

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Role of Blinatumomab in Minimal Residual Disease and Hematologic Relapsed/Refractory Adult Acute Lymphoblastic Leukemia Patients Treated over 5 Years. a Single Center Experience
Background. Hematologic and, to a lesser extent, molecular relapsed/refractory in adult acute lymphoblastic leukemia (R/R ALL) is… 
2018
2018
[The investigation of CAG regimen in relapsed and refractory adult acute lymphoblastic leukemia].
2012
2012
Clofarabine‐based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience
The present study reports the Spanish PETHEMA group experience in 31 heavily pretreated relapsed/refractory acute lymphoblastic… 
2011
2011
Clofarabine-Based Chemotherapy for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. the Spanish Experience
Abstract 4246 Background: Patients with relapsed/refractory acute lymphoblastic leukemia (ALL) have a very poor outcome with… 
2009
2009
A phase II feasibility study of cytarabine and idarubicin combination in relapsed or refractory adult acute lymphoblastic leukemia.
e18002 Background: Most patients with adult ALL eventually relapse. Salvage regimens in these patients and in patients with… 
2006
2006
Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG)
Outcome of adults with acute lymphoblastic leukemia (ALL) who fail to achieve complete remission (CR) or who relapse soon after… 
2000
2000
A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia.
1998
1998
A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia
Relapsed or refractory adult acute lymphoblastic leukemia (ALL) carries a grave prognosis. The most promising strategy for curing… 
1986
1986
Therapy of Refractory Adult Acute Lymphoblastic Leukemia with Vincristine and Prednisone plus Tandem Methotrexate and L‐Asparaginase Results of a Cancer and Leukemia Group B Study
Methotrexate (MTX) and L-asparaginase (ASP) are effective agents in the treatment of acute lymphoblastic leukemia (ALL). The… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)